Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Sam68 binds Alu-rich introns in SMN and promotes pre-mRNA circularization.

Pagliarini V, Jolly A, Bielli P, Di Rosa V, De la Grange P, Sette C.

Nucleic Acids Res. 2019 Nov 28. pii: gkz1117. doi: 10.1093/nar/gkz1117. [Epub ahead of print]

PMID:
31777926
2.

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.

Capone A, Bianco M, Ruocco G, De Bardi M, Battistini L, Ruggieri S, Gasperini C, Centonze D, Sette C, Volpe E.

Cells. 2019 Jun 4;8(6). pii: E533. doi: 10.3390/cells8060533.

3.

The Promoter-Associated Noncoding RNA pncCCND1_B Assembles a Protein-RNA Complex to Regulate Cyclin D1 Transcription in Ewing Sarcoma.

Palombo R, Frisone P, Fidaleo M, Mercatelli N, Sette C, Paronetto MP.

Cancer Res. 2019 Jul 15;79(14):3570-3582. doi: 10.1158/0008-5472.CAN-18-2403. Epub 2019 May 9.

PMID:
31072811
4.

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer.

Caggiano C, Pieraccioli M, Panzeri V, Sette C, Bielli P.

Nucleic Acids Res. 2019 Jul 9;47(12):6160-6171. doi: 10.1093/nar/gkz344.

5.

Functional Interaction between U1snRNP and Sam68 Insures Proper 3' End Pre-mRNA Processing during Germ Cell Differentiation.

Naro C, Pellegrini L, Jolly A, Farini D, Cesari E, Bielli P, de la Grange P, Sette C.

Cell Rep. 2019 Mar 12;26(11):2929-2941.e5. doi: 10.1016/j.celrep.2019.02.058.

6.

Drug resistance in pancreatic cancer: New player caught in act.

Capurso G, Sette C.

EBioMedicine. 2019 Feb;40:39-40. doi: 10.1016/j.ebiom.2019.02.008. Epub 2019 Feb 11. No abstract available.

7.

The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer.

Bielli P, Di Stasi SM, Sette C.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S765-S767. doi: 10.21037/tau.2018.12.01. No abstract available.

8.

The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29.

Volpe E, Cesari E, Mercatelli N, Cicconi R, De Bardi M, Capone A, Bonvissuto D, Fraziano M, Mattei M, Battistini L, Paronetto MP, Sette C.

Cell Death Differ. 2019 Jun;26(6):1169-1180. doi: 10.1038/s41418-018-0201-9. Epub 2018 Sep 26.

PMID:
30258098
9.

Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis.

Madaro L, Passafaro M, Sala D, Etxaniz U, Lugarini F, Proietti D, Alfonsi MV, Nicoletti C, Gatto S, De Bardi M, Rojas-GarcĂ­a R, Giordani L, Marinelli S, Pagliarini V, Sette C, Sacco A, Puri PL.

Nat Cell Biol. 2018 Aug;20(8):917-927. doi: 10.1038/s41556-018-0151-y. Epub 2018 Jul 26.

10.

The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.

Bielli P, Panzeri V, Lattanzio R, Mutascio S, Pieraccioli M, Volpe E, Pagliarulo V, Piantelli M, Giannantoni A, Di Stasi SM, Sette C.

Clin Cancer Res. 2018 Nov 1;24(21):5422-5432. doi: 10.1158/1078-0432.CCR-17-3850. Epub 2018 Jul 16.

11.

TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Rossin F, Villella VR, D'Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, Raia V, Maiuri L, Piacentini M.

EMBO Rep. 2018 Jul;19(7). pii: e45067. doi: 10.15252/embr.201745067. Epub 2018 May 11.

12.

Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death.

Passacantilli I, Panzeri V, Terracciano F, Delle Fave G, Sette C, Capurso G.

Oncol Rep. 2018 Apr;39(4):1984-1990. doi: 10.3892/or.2018.6233. Epub 2018 Jan 25.

PMID:
29393478
13.

Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells.

Passacantilli I, Panzeri V, Bielli P, Farini D, Pilozzi E, Fave GD, Capurso G, Sette C.

Cell Death Dis. 2017 Nov 9;8(11):e3168. doi: 10.1038/cddis.2017.562.

14.

Timely-regulated intron retention as device to fine-tune protein expression.

Naro C, Sette C.

Cell Cycle. 2017 Jul 18;16(14):1321-1322. doi: 10.1080/15384101.2017.1337983. Epub 2017 Jun 8. No abstract available.

15.
16.

Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation.

Svetoni F, De Paola E, La Rosa P, Mercatelli N, Caporossi D, Sette C, Paronetto MP.

Hum Mol Genet. 2017 Jul 15;26(14):2732-2746. doi: 10.1093/hmg/ddx160.

PMID:
28453628
17.

Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Pagliarini V, La Rosa P, Sette C.

Hum Genet. 2017 Sep;136(9):1215-1235. doi: 10.1007/s00439-017-1802-y. Epub 2017 Apr 22. Review.

PMID:
28434044
18.

An Orchestrated Intron Retention Program in Meiosis Controls Timely Usage of Transcripts during Germ Cell Differentiation.

Naro C, Jolly A, Di Persio S, Bielli P, Setterblad N, Alberdi AJ, Vicini E, Geremia R, De la Grange P, Sette C.

Dev Cell. 2017 Apr 10;41(1):82-93.e4. doi: 10.1016/j.devcel.2017.03.003. Epub 2017 Mar 30.

19.

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.

Pradella D, Naro C, Sette C, Ghigna C.

Mol Cancer. 2017 Jan 30;16(1):8. doi: 10.1186/s12943-016-0579-2. Review.

20.

A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse Behavior.

Ehrmann I, Gazzara MR, Pagliarini V, Dalgliesh C, Kheirollahi-Chadegani M, Xu Y, Cesari E, Danilenko M, Maclennan M, Lowdon K, Vogel T, Keskivali-Bond P, Wells S, Cater H, Fort P, Santibanez-Koref M, Middei S, Sette C, Clowry GJ, Barash Y, Cunningham MO, Elliott DJ.

Cell Rep. 2016 Dec 20;17(12):3269-3280. doi: 10.1016/j.celrep.2016.12.002.

Supplemental Content

Loading ...
Support Center